Introduction

Assisting patients with the actualization of their gender identity can be an incredibly rewarding part of primary care.

Health care professionals increasingly agree that trans and non-binary (TNB) communities are an underserved population whose needs can be effectively addressed in primary care.1

Studies show that the trans community is among the most underserved groups within the 2SLGBTQ+ population. Contributing factors include marginalization, discrimination, inadequate provider knowledge, insufficient services, and structural barriers.2

Trans PULSE Canada reports that of the 1,012 TNB people surveyed in Ontario, 42% had an unmet health care need in the past year and 12% had avoided the emergency room.3

The mental health toll of these inequities is significant.

Trans PULSE Canada found that 54% of participants self-rated their mental health as fair or poor, 31% had considered suicide in the past year, and 5% had attempted suicide.3

Why is access to gender-affirming care important?

Many TNB people seek medical assistance to align their physical appearance with their gender identity, often through hormone therapy or surgery, and provider support for this process can profoundly improve their well-being. A Canadian study of trans people in Ontario found that among those who needed to medically transition, completing a medical transition through hormones and/or surgeries was associated with large and significant reductions in suicide risk.4

Health care provider shaking hand of trans woman

What are barriers to gender-affirming care?

It remains a frequent challenge for TNB people to access health care services for general and transition-related health care needs. Many have had negative experiences including discomfort, denial of care, and discrimination.

52.3%
TNB respondents had a primary care provider they felt comfortable discussing trans health issues with.5
59%
Trans respondents reported noticing a negative/very negative change in provider behaviour following disclosure.6
30%
About one-third of trans (31%), non-binary (30%) and Two Spirit (36%) respondents reported being denied care or treated unequally.6

What is the role of primary care?

Primary care providers play an increasingly important role in delivering gender-affirming care to TNB patients. Because they typically have a familiar, longitudinal relationship with their patients, they are ideally situated to facilitate and support the transition process. In most cases, providing hormone therapy falls within the scope of primary care.

Referral to an endocrinologist may be appropriate and helpful, particularly for medically complex patients, but it is not required as a matter of course for most TNB patients.

Outside major urban areas, an endocrinologist with experience treating gender-diverse patients may not be available, and requiring a consultation can result in an unduly long and stressful wait.

What are common fears around providing hormone therapy?

Hormone therapy need not be specialist care.

According to WPATH, primary care providers are well suited to support and care for this medically underserved population:

  • You are familiar with your individual patients.
  • You have knowledge of hormone use in other populations—such as postmenopausal cis women or hypogonadal cis men—and can apply this knowledge to trans and non-binary patients using hormones for gender transition.
  • You are accustomed to empowering patients through education and shared decision-making.
  • Knowledgeable providers are available to provide input when support is needed (for additional resources, visit Rainbow Health Ontario Courses, Rainbow Health Ontario Trans Mentorship Call, and Ontario eConsult Program).

If a patient’s case is medically complex, a referral can be helpful, but it is not routinely necessary. In areas where an experienced endocrinologist is unavailable, waiting for a consultation can create a long and stressful delay. In such cases, it may be reasonable to start an androgen blocker, with or without low-dose estrogen (for example, half the regular dosage) for transfeminine patients, or low-dose testosterone for transmasculine patients, while awaiting the appointment.

According to WPATH, primary care providers are well suited to support and care for this medically underserved population. A review of the available literature and the combined years of experience at Sherbourne Health and similar centres demonstrates that hormone therapy has a favourable safety profile when provided under medical supervision.1 It remains a life-saving measure even for patients with minor or significant health issues. Denying access to hormones can do more harm than the possible risks of treatment.

A 2021 systematic review found an extremely low prevalence of regret among trans patients after gender-affirming surgery: <1% for transmasculine procedures and 1% for transfeminine procedures.7 By comparison, rates of regret for knee and hip surgeries are significantly higher, at 17.1% and 4.8%, respectively.8 Importantly, regret for transition is often driven by external pressures such as discrimination, lack of social support, or financial barriers rather than a change in gender identity.9

  1. Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health. 2022;23(Suppl 1):S1–S259. doi:10.1080/26895269.2022.2100644.
  2. Comeau D, Johnson C, Bouhamdani N. Review of current 2SLGBTQIA+ inequities in the Canadian health care system. Front Public Health. 2023;11:1183284. doi:10.3389/fpubh.2023.1183284.
  3. The Trans PULSE Canada Team. Health and health care access for trans and non-binary people in Canada. 2020 Mar 10 [cited 2026 Sep 25]. Available from: https://transpulsecanada.ca/results/report-1/.
  4. Bauer GR, Scheim AI, Pyne J, Travers R, Hammond R. Intervenable factors associated with suicide risk in transgender persons: a respondent driven sampling study in Ontario, Canada. BMC Public Health. 2015;15:525. doi:10.1186/s12889-015-1867-2.
  5. Scheim AI, Coleman T, Lachowsky N, Bauer GR. Health care access among transgender and nonbinary people in Canada, 2019: a cross-sectional survey. CMAJ Open. 2021;9(4):E1213–22. doi:10.9778/cmajo.20210061.
  6. Bouhamdani N, Bouhamdani D, Custodio A, Hara G, McGuire J. PTP pink paper: 2SLGBTQIA+ health disparities in Canada. Toronto: Pink Triangle Press; 2026 [cited 2026 Sep 25]. Available from: https://www.pinktrianglepress.com/advocacy/ptp-pink-paper/.
  7. Bustos VP, Bustos SS, Mascaro A, Del Corral G, Forte AJ, Ciudad P, Kim EA, Langstein HN, Manrique OJ. Regret after gender-affirmation surgery: a systematic review and meta-analysis of prevalence. Plast Reconstr Surg Glob Open. 2021;9(3):e3477. doi:10.1097/GOX.0000000000003477.
  8. Cassidy RS, Bennett DB, Beverland DE, O’Brien S. Decision regret after primary hip and knee replacement surgery. J Orthop Sci. 2023;28(1):167–72. doi:10.1016/j.jos.2021.10.019.
  9. Turban JL, Loo SS, Almazan AN, Keuroghlian AS. Factors leading to “detransition” among transgender and gender diverse people in the United States: a mixed-methods analysis. LGBT Health. 2021 May-Jun;8(4):273–80. doi:10.1089/lgbt.2020.0437.